Telesis Bio, Inc. - stock earnings

TBIO Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 8, 2024 AfterMarket - / -0.2346000000 - - / 7.0 million -

TBIO Quarterly earnings

DateEarningsRevenue
2023Q3 -10.6 million USD 5.6 million USD
2023Q2 -8.3 million USD 8.7 million USD
2023Q1 -11.1 million USD 6.3 million USD
2022Q4 -8.1 million USD 9.5 million USD
2022Q3 -12.3 million USD 6.7 million USD
2022Q2 -14.8 million USD 5.7 million USD
2022Q1 -13.2 million USD 5.6 million USD
2021Q4 -12.5 million USD 3.1 million USD
2021Q3 -9.8 million USD 2.8 million USD
2021Q2 -9.2 million USD 2.9 million USD
2021Q1 -7.4 million USD 2.3 million USD
2020Q4 -5.6 million USD 1.9 million USD
2020Q3 -4.5 million USD 1.6 million USD
2020Q2 -4.1 million USD 1.6 million USD
2020Q1 -3.9 million USD 1.4 million USD
2019Q4 -31.0 million USD 3.9 million USD
2019Q3 -21.2 million USD 1.3 million USD
2019Q2 -27.8 million USD 1.2 million USD
2019Q1 -33.2 million USD 1.5 million USD
2018Q4 -6.0 million USD 1.2 million USD
2018Q3 -42.6 million USD 238000 USD
2018Q2 -27.5 million USD ? USD
2018Q1 -21.2 million USD ? USD
2017Q4 -16.1 million USD ? USD
2017Q3 -18.5 million USD ? USD
2017Q2 -17.9 million USD ? USD
2017Q1 -14.0 million USD ? USD

TBIO Yearly earnings

DateEarningsRevenue
2023 -38.2 million USD 30.0 million USD
2022 -48.5 million USD 27.4 million USD
2021 -39.0 million USD 11.0 million USD
2020 -18.0 million USD 6.6 million USD
2019 -8.3 million USD 4.8 million USD
2018 -97.4 million USD 1.4 million USD
2017 -66.4 million USD ? USD
2016 -26.7 million USD ? USD

TBIO

Price: $0.31

52 week price:
0.30
3.01

Earnings Per Share: -1.64 USD

P/E Ratio: -0.25

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 19200

Market Capitalization: 9.9 million

Links: